Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Enjuanes L, Dediego ML, Alvarez E, Deming D, Sheahan T, Baric R.

Virus Res. 2008 Apr;133(1):45-62. Epub 2007 Apr 9.

PMID:
17416434
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.

Tseng CT, Sbrana E, Iwata-Yoshikawa N, Newman PC, Garron T, Atmar RL, Peters CJ, Couch RB.

PLoS One. 2012;7(4):e35421. doi: 10.1371/journal.pone.0035421. Epub 2012 Apr 20. Erratum in: PLoS One. 2012;7(8). doi:10.1371/annotation/2965cfae-b77d-4014-8b7b-236e01a35492.

PMID:
22536382
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.

Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, Collins PL.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9. Epub 2004 Jun 21.

PMID:
15210961
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.

Fett C, DeDiego ML, Regla-Nava JA, Enjuanes L, Perlman S.

J Virol. 2013 Jun;87(12):6551-9. doi: 10.1128/JVI.00087-13. Epub 2013 Apr 10.

PMID:
23576515
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).

Suresh MR, Bhatnagar PK, Das D.

J Pharm Pharm Sci. 2008 Apr 19;11(2):1s-13s.

PMID:
19203466
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

SARS vaccines: where are we?

Roper RL, Rehm KE.

Expert Rev Vaccines. 2009 Jul;8(7):887-98. doi: 10.1586/erv.09.43. Review.

PMID:
19538115
[PubMed - indexed for MEDLINE]
7.

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.

Du L, Zhao G, He Y, Guo Y, Zheng BJ, Jiang S, Zhou Y.

Vaccine. 2007 Apr 12;25(15):2832-8. Epub 2006 Oct 30.

PMID:
17092615
[PubMed - indexed for MEDLINE]
8.

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.

Liu YV, Massare MJ, Barnard DL, Kort T, Nathan M, Wang L, Smith G.

Vaccine. 2011 Sep 2;29(38):6606-13. doi: 10.1016/j.vaccine.2011.06.111. Epub 2011 Jul 14.

PMID:
21762752
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.

Bolles M, Deming D, Long K, Agnihothram S, Whitmore A, Ferris M, Funkhouser W, Gralinski L, Totura A, Heise M, Baric RS.

J Virol. 2011 Dec;85(23):12201-15. doi: 10.1128/JVI.06048-11. Epub 2011 Sep 21.

PMID:
21937658
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.

Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ.

Nature. 2004 Apr 1;428(6982):561-4.

PMID:
15024391
[PubMed - indexed for MEDLINE]
11.

Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.

Cavanagh D.

Avian Pathol. 2003 Dec;32(6):567-82. Review.

PMID:
14676007
[PubMed - indexed for MEDLINE]
12.

Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.

Iwata-Yoshikawa N, Uda A, Suzuki T, Tsunetsugu-Yokota Y, Sato Y, Morikawa S, Tashiro M, Sata T, Hasegawa H, Nagata N.

J Virol. 2014 Aug;88(15):8597-614. doi: 10.1128/JVI.00983-14. Epub 2014 May 21.

PMID:
24850731
[PubMed - indexed for MEDLINE]
13.

Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.

Lu B, Huang Y, Huang L, Li B, Zheng Z, Chen Z, Chen J, Hu Q, Wang H.

Immunology. 2010 Jun;130(2):254-61. doi: 10.1111/j.1365-2567.2010.03231.x. Epub 2010 Apr 6.

PMID:
20406307
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.

Spruth M, Kistner O, Savidis-Dacho H, Hitter E, Crowe B, Gerencer M, Brühl P, Grillberger L, Reiter M, Tauer C, Mundt W, Barrett PN.

Vaccine. 2006 Jan 30;24(5):652-61. Epub 2005 Aug 26.

PMID:
16214268
[PubMed - indexed for MEDLINE]
15.

Vaccine design for severe acute respiratory syndrome coronavirus.

He Y, Jiang S.

Viral Immunol. 2005;18(2):327-32. Review.

PMID:
16035944
[PubMed - indexed for MEDLINE]
16.

Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.

Callendret B, Lorin V, Charneau P, Marianneau P, Contamin H, Betton JM, van der Werf S, Escriou N.

Virology. 2007 Jul 5;363(2):288-302. Epub 2007 Feb 28.

PMID:
17331558
[PubMed - indexed for MEDLINE]
Free Article
17.

Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.

See RH, Zakhartchouk AN, Petric M, Lawrence DJ, Mok CP, Hogan RJ, Rowe T, Zitzow LA, Karunakaran KP, Hitt MM, Graham FL, Prevec L, Mahony JB, Sharon C, Auperin TC, Rini JM, Tingle AJ, Scheifele DW, Skowronski DM, Patrick DM, Voss TG, Babiuk LA, Gauldie J, Roper RL, Brunham RC, Finlay BB.

J Gen Virol. 2006 Mar;87(Pt 3):641-50.

PMID:
16476986
[PubMed - indexed for MEDLINE]
Free Article
18.

Animal coronavirus vaccines: lessons for SARS.

Saif LJ.

Dev Biol (Basel). 2004;119:129-40. Review.

PMID:
15742624
[PubMed - indexed for MEDLINE]
19.

Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

Chou TH, Wang S, Sakhatskyy PV, Mboudjeka I, Lawrence JM, Huang S, Coley S, Yang B, Li J, Zhu Q, Lu S.

Virology. 2005 Mar 30;334(1):134-43. Erratum in: Virology. 2005 Jun 20;337(1):204. Mboudoudjeck, Innocent [corrected to Mboudjeka, Innocent].

PMID:
15749129
[PubMed - indexed for MEDLINE]
Free Article
20.

Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine.

Qin E, Shi H, Tang L, Wang C, Chang G, Ding Z, Zhao K, Wang J, Chen Z, Yu M, Si B, Liu J, Wu D, Cheng X, Yang B, Peng W, Meng Q, Liu B, Han W, Yin X, Duan H, Zhan D, Tian L, Li S, Wu J, Tan G, Li Y, Li Y, Liu Y, Liu H, Lv F, Zhang Y, Kong X, Fan B, Jiang T, Xu S, Wang X, Li C, Wu X, Deng Y, Zhao M, Zhu Q.

Vaccine. 2006 Feb 13;24(7):1028-34. Epub 2005 Sep 12.

PMID:
16388880
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk